USSTOCK.TODAY
Regular Market
Log in Sign up

FTC and 7 States Seek Contempt Charges Against Martin Shkreli, Banned from Pharmaceutical Industry

Investing.com +1 ·

  1. 1The Federal Trade Commission (FTC) and 7 states are pursuing contempt of court charges, alleging Martin Shkreli violated his ban from the pharmaceutical industry.
  2. 2Shkreli traded shares in at least 60 pharmaceutical companies and discussed trading strategies via live streaming.
  3. 3In January 2022, Shkreli's damages for antitrust violations were set at $64.6 million.

So what's the key point?

Martin Shkreli, who was banned from the pharmaceutical industry, is suspected of breaking the law by secretly trading stocks. Because of this, Shkreli could be held responsible for disregarding the court.

Source Investing.com +1 · View original ↗

Related 3-line summaries

BioHarvest Sciences Announces Commercial Readiness of Olive Cell Composition Newsfile Corp. +1 · 3h agoCipher Digital Inc. shares fall 12% following announcement of $850,000,000 zero-interest convertible bond issuance Investing.com +3 · 2h agoMatthew DiRalo Buys Procter & Gamble Based on Low Valuation and High Dividend Yield Nasdaq +1 · 2h ago
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news